IBDEI044 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1580,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1580,1,4,0)
 ;;=4^414.03
 ;;^UTILITY(U,$J,358.3,1580,1,5,0)
 ;;=5^Cor Atheroscl Nonauto Bio Byp Graph
 ;;^UTILITY(U,$J,358.3,1580,2)
 ;;=^303283
 ;;^UTILITY(U,$J,358.3,1581,0)
 ;;=414.05^^11^130^15
 ;;^UTILITY(U,$J,358.3,1581,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1581,1,4,0)
 ;;=4^414.05
 ;;^UTILITY(U,$J,358.3,1581,1,5,0)
 ;;=5^Cor Ather/Unspec Type Byp Graph
 ;;^UTILITY(U,$J,358.3,1581,2)
 ;;=^304308
 ;;^UTILITY(U,$J,358.3,1582,0)
 ;;=414.12^^11^130^17
 ;;^UTILITY(U,$J,358.3,1582,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1582,1,4,0)
 ;;=4^414.12
 ;;^UTILITY(U,$J,358.3,1582,1,5,0)
 ;;=5^Dissection of Coronary Artery
 ;;^UTILITY(U,$J,358.3,1582,2)
 ;;=^328493
 ;;^UTILITY(U,$J,358.3,1583,0)
 ;;=414.19^^11^130^3
 ;;^UTILITY(U,$J,358.3,1583,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1583,1,4,0)
 ;;=4^414.19
 ;;^UTILITY(U,$J,358.3,1583,1,5,0)
 ;;=5^Aneurysm of Heart NEC
 ;;^UTILITY(U,$J,358.3,1583,2)
 ;;=^87338
 ;;^UTILITY(U,$J,358.3,1584,0)
 ;;=429.5^^11^131^3
 ;;^UTILITY(U,$J,358.3,1584,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1584,1,4,0)
 ;;=4^429.5
 ;;^UTILITY(U,$J,358.3,1584,1,5,0)
 ;;=5^Rupture Chordae Tendineae
 ;;^UTILITY(U,$J,358.3,1584,2)
 ;;=^269732
 ;;^UTILITY(U,$J,358.3,1585,0)
 ;;=429.6^^11^131^4
 ;;^UTILITY(U,$J,358.3,1585,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1585,1,4,0)
 ;;=4^429.6
 ;;^UTILITY(U,$J,358.3,1585,1,5,0)
 ;;=5^Rupture Papillary Muscl
 ;;^UTILITY(U,$J,358.3,1585,2)
 ;;=^269735
 ;;^UTILITY(U,$J,358.3,1586,0)
 ;;=429.71^^11^131^1
 ;;^UTILITY(U,$J,358.3,1586,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1586,1,4,0)
 ;;=4^429.71
 ;;^UTILITY(U,$J,358.3,1586,1,5,0)
 ;;=5^Acq Cardiac Septl Defect
 ;;^UTILITY(U,$J,358.3,1586,2)
 ;;=^269738
 ;;^UTILITY(U,$J,358.3,1587,0)
 ;;=443.81^^11^131^2
 ;;^UTILITY(U,$J,358.3,1587,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1587,1,4,0)
 ;;=4^443.81
 ;;^UTILITY(U,$J,358.3,1587,1,5,0)
 ;;=5^Angiopathy in Other Diseases
 ;;^UTILITY(U,$J,358.3,1587,2)
 ;;=^92164
 ;;^UTILITY(U,$J,358.3,1588,0)
 ;;=401.0^^11^132^20
 ;;^UTILITY(U,$J,358.3,1588,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1588,1,4,0)
 ;;=4^401.0
 ;;^UTILITY(U,$J,358.3,1588,1,5,0)
 ;;=5^Malignant Hypertension
 ;;^UTILITY(U,$J,358.3,1588,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,1589,0)
 ;;=796.2^^11^132^7
 ;;^UTILITY(U,$J,358.3,1589,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1589,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,1589,1,5,0)
 ;;=5^Elev BP W/O Hypertension
 ;;^UTILITY(U,$J,358.3,1589,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,1590,0)
 ;;=402.00^^11^132^16
 ;;^UTILITY(U,$J,358.3,1590,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1590,1,4,0)
 ;;=4^402.00
 ;;^UTILITY(U,$J,358.3,1590,1,5,0)
 ;;=5^Malignant HTN HRT Disease
 ;;^UTILITY(U,$J,358.3,1590,2)
 ;;=^269594
 ;;^UTILITY(U,$J,358.3,1591,0)
 ;;=402.01^^11^132^17
 ;;^UTILITY(U,$J,358.3,1591,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1591,1,4,0)
 ;;=4^402.01
 ;;^UTILITY(U,$J,358.3,1591,1,5,0)
 ;;=5^Malignant HTN HRT W/CHF
 ;;^UTILITY(U,$J,358.3,1591,2)
 ;;=^269595
 ;;^UTILITY(U,$J,358.3,1592,0)
 ;;=402.10^^11^132^1
 ;;^UTILITY(U,$J,358.3,1592,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1592,1,4,0)
 ;;=4^402.10
 ;;^UTILITY(U,$J,358.3,1592,1,5,0)
 ;;=5^Benign HTN HRT Disease
 ;;^UTILITY(U,$J,358.3,1592,2)
 ;;=^269598
 ;;^UTILITY(U,$J,358.3,1593,0)
 ;;=402.11^^11^132^2
 ;;^UTILITY(U,$J,358.3,1593,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1593,1,4,0)
 ;;=4^402.11
 ;;^UTILITY(U,$J,358.3,1593,1,5,0)
 ;;=5^Benign HTN HRT W/CHF
 ;;^UTILITY(U,$J,358.3,1593,2)
 ;;=^269599
